November 29, 2015
MEDICEPTION successfully finishes the Ph IV clinical protocol of a Fixed Dose Combination (FDC) towards COPD indication for a top pharma company from India, to be launched in Indian market.
I'm busy working on my blog posts. Watch this space!
Real World Evidence (RWE) Ph IV Studies
April 15, 2019
Sponsoring 10th Clinical Trial Symposium, Mumbai
April 12, 2019
Preparation of complete eCTD dossiers
April 10, 2019
MEDICEPTION ranked 8th in top 10 companies
April 8, 2019
Publication of article "SGLT2 inhibitors in Diabetes"
April 6, 2019